Back to CYTR Stock Lookup

CytRx (CYTR) – Press Releases

Sep 22, 2014 06:00 AM CytRx Announces Presentation of Aldoxorubicin Global Phase 3 Soft Tissue Sarcomas and Global Phase 2b Small Cell Lung Cancer Trial Designs at ESMO 2014 Congress
Sep 19, 2014 06:00 AM CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference
Sep 15, 2014 03:23 PM Former Louisiana Attorney General and KSF Announce Appointment as Lead Counsel in CytRx Securities Fraud Lawsuit: Secondary Offering Shareholders (January 31, 2014) Should Inquire For More Information
Sep 15, 2014 09:01 AM Zeldes & Haeggquist, LLP Continues Investigation of CytRx Corporation
Sep 9, 2014 06:00 AM CytRx Initiates Phase 1b Clinical Trial with Combination of Aldoxorubicin and Ifosfamide/Mesna as First-Line Treatment in Patients with Advanced Sarcomas
Sep 5, 2014 06:00 AM CytRx Updates Presentation Time at Aegis 2014 Healthcare & Technology Conference
Sep 2, 2014 06:00 AM CytRx to Present at Upcoming Investor Conferences in New York City and Las Vegas
Aug 11, 2014 08:00 AM Rodman & Renshaw 2014 Annual Global Investment Conference to be held in New York from September 8 to 10, 2014
Aug 7, 2014 06:00 AM Oral Presentation of CytRx’s Aldoxorubicin Phase 2b Clinical Trial in Soft Tissue Sarcoma Highlighted in The Lancet Oncology
Aug 6, 2014 06:00 AM CytRx Reports 2014 Second Quarter Financial Results
Jun 30, 2014 06:00 AM CytRx Added to Russell 3000® and Russell 2000® Indexes

Back to CYTR Stock Lookup